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A B S T R A C T
Background: Percutaneous coronary intervention (PCI) for bifurcation lesions (BL) using 2 stents
technique is known to be associated with high rates of procedural failure especially on the side branch
(SB) mainly due to stent incomplete apposition. Stent deployment at very high pressure (SDHP) may lead
to better stent expansion and apposition. However, SDHP may also be at the origin of deeper wall injury
resulting into major cardiac adverse events. No data are available on evaluation of SDHP in BL treated by
a mini-crush stent technique.
Methods: One hundred and thirteen consecutive patients underwent PCI for BL (Medina 1, 1, 1) using a
mini-crush stent technique with SDHP deﬁned as 20 atm. An angiographic follow-up was performed at
6 month and clinical follow-up was obtained at a median of 3 years.
Results: Stent deployment mean pressures were 20  1.4 atm (range 20–25) in the main vessel (MV) and
20  1.5 atm (range 20–25) in SB. Simultaneous ﬁnal kissing balloon was used in 92% of cases. PCI was
successful in 100%. Angiographic follow-up was obtained in 83% of patients. Restenosis rate was 13% (12%
restenosis in the SB) with only one case (0.8%) of SB probable thrombosis. Another case of late stent
thrombosis occurred at a 3 years clinical follow-up.
Conclusion: Compared with previously published studies in which stents were deployed at lower
pressure, SDHP does not increase the restenosis rate in BL using mini-crush stent technique but seems to
reduce the rate of stent thrombosis.
 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The treatment of coronary bifurcation remains a challenge for
interventional cardiologists. Randomized trials and meta-analysis
suggest that bifurcation lesions (BL) treatment using a one-stent
strategy with provisional stenting (PS) of the side branch (SB)
results into better clinical outcomes when compared with two-
stent techniques.1,2 However, many cases of BL cannot be treated
by a one-stent strategy. Situations such as long severe ostial
stenosis on a large SB as well as major dissection or severe residual
stenosis on the SB after main vessel stenting still require a two-
stent technique. Therefore, various bifurcation stent techniques
have been proposed.3–7 The ‘‘crush and mini-crush’’ techniques are
two-stent strategies that ensure a complete coverage of the SB* Corresponding author at: Service de cardiologie, Hoˆpital Nord, Centre
Hospitalo-Universitaire de Saint Etienne, 42055 Saint Etienne Cedex 2, France.
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licenses/by-nc-nd/4.0/).ostium but despite the use of drug eluting stent (DES), these
procedures are still associated with relatively high procedural
complications and restenosis rate.8–10 Procedural failure in PCI of
BL may be explained in part by incomplete stent apposition that
may occur more frequently than in simple lesions. Both stent
deployment (SD) at very high pressure (HP) and HP simultaneous
ﬁnal kissing balloon (SFKB) may improve stent apposition and
therefore reduce cardiovascular events. On the other hand, some
data are in favor of less aggressive strategy for stent deployment
without using HP inﬂation in non-BL suggesting that SDHP may be
at the origin of deeper wall injury provoking a neointimal response
that can be responsible for diffuse in-stent restenosis and
subsequently increase in major cardiac adverse events (MACE)
rates.11,12 No data are available on evaluation of SDHP in BL treated
by a mini-crush stent technique. The aim of our prospective study
was to evaluate the impact of SDHP and HP SFKB with a ‘‘mini-
crush’’ stenting technique in BL on both angiographic restenosis
and clinical outcome.ressure stent deployment on angiographic and long-term clinical
rush stent technique: A single center experience, Indian Heart J.
 open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
Population characteristics (n = 113).






Artheriopathy of the lower limbs (%) 8
Family history (%) 35.4
Renal insufﬁciency (%) 3.5
Left ventricular ejection fraction (%) 60  13.4
Stress test or SPECT (%) 35.5
Stable angina (%) 15.9
Instable angina (%) 27.4
STEMI (%) 21.2
STEMI, ST elevation myocardial infarction; SPECT, single
photoemission computed tomography.
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2.1. Study population
From May 2010 to March 2014, a total of 113 successive
patients underwent a two-stent strategy in PCI for the treatment of
complex coronary bifurcation lesion (Medina 1, 1, 1) using a mini-
crush technique with HP implantation and HP SFKB. A signed
informed consent was obtained from all patients.
2.2. Interventional procedure
All patients were given a loading dose of 300 mg clopidogrel
when not pretreated and 100 mg aspirin the day before the
procedure. Bolus intravenous injection of unfractionated Heparin
(5000 UI) and 250 mg aspirin was administered at the beginning of
the procedure. All patients received DES. Different generations of
DES were used including sirolimus eluting stents (SES, Cypher,
Cordis Corporation), zotarolimus eluting stents (ZES, Resolute,
Medtronic), everolimus eluting stents (EES, Xience, Abbott
Vascular) and biolimus eluting stents (BES, Biomatrix, Biosensor).
Procedures were performed using either transfemoral or transra-
dial approach. A 6 Fr arterial sheath was used for transradial
approach and 6 Fr, 7 Fr or 8 Fr arterial sheaths were used for
transfemoral approach. In some cases, we used a simultaneous
dual vascular access site (radial–radial, radio-femoral or femoro-
femoral) that allows simultaneous positioning of the two-stent
delivery systems through 2 individual guiding catheters. Once the
guiding catheter was positioned in the ostium of the coronary
artery, a ﬁrst guidewire was advanced into the distal main vessel
(DMV) and a second guidewire was advanced into the side branch
(SB). Balloon pre-dilatation was performed at the discretion of the
operator. An appropriately sized stent (1:1 stent-to-artery diame-
ter ratio) was ﬁrst implanted in the SB using quantitative coronary
analysis sizing and positioned to cover the whole lesion with the
distal part of the stent in an angiographically healthy arterial
segment. When a 6 Fr sheath was used, a non-compliant balloon
(Quantum Maverick Balloon, Boston Scientiﬁc Corporation) with a
size matched to the main vessel diameter was positioned in front of
the SB stent to avoid main vessel occlusion during SB stent
deployment or difﬁculty to make progress material into the DMV
after SB stent deployment. The SB stent was ﬁrst deployed at
12 atm to avoid downstream dissection and after a slight pullback
of the stent balloon, another inﬂation was systematically
performed at 20 atm to ensure optimized stent apposition. The
guidewire and the balloon used for the stent deployment were
then removed from the SB. The non-compliant balloon located in
the main vessel was then inﬂated at 20 atm to crush the 1–2 mm
proximal side branch stent. When a 7 Fr sheath was used, the SB
stent was directly crushed by the main vessel stent. For the main
vessel, a stent was chosen with a size matched to the diameter of
the DMV (diameters ratio = 1:1) using a quantitative coronary
analysis system and it was ﬁrst deployed at 12 atm. After initial
stent deployment in the main vessel, proximal optimization
technique was used to match the stent size to the proximal main
vessel diameter with the same stent balloon using inﬂation at very
high pressure (20–25 atm) or with another larger non-compliant
balloon. Finally, a ﬂoppy or hydrophilic guidewire was advanced
across the stents struts into the side branch and a HP SFKB was
performed using 2 non-compliant balloons. The SB non-compliant
balloon was ﬁrst inﬂated at 20 atm and deﬂated after 10 s. The SB
non-compliant balloon was shorter than the SB stent for avoid
downstream dissection and this size was the same as that of the SB
stent (which was determined by QCA). Then, the MV balloon was
inﬂated at 20 atm (the size was chosen with de DMV stent also
determined by QCA). Finally, a SFKB was done with a simultaneousPlease cite this article in press as: Gerbay A, et al. Impact of very high p
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(2016), http://dx.doi.org/10.1016/j.ihj.2016.05.013inﬂation of the balloon at median of 17 and 18 atm. The two
balloons were pulled back to the part proximal of the MV stent and
another inﬂation was done. Angiographic success was deﬁned as
residual stenosis less than 20% in both branches with a TIMI ﬂow
grade 3.
2.3. Angiographic and clinical follow-up
All patients were planned to have a routine control coronary
angiogram at a mean of 6 months. Binary angiographic restenosis
was deﬁned as 50% diameter stenosis by a visual analysis. Stent
thrombosis was deﬁned according to the Academic Research
Consortium deﬁnition.13 Major cardiac adverse were deﬁned by all
cause death, cardiovascular death, non-cardiovascular death, Q
wave myocardial infarction, no Q wave myocardial infarction,
target vessel revascularization (TVR), target lesion revasculariza-
tion (TLR), strokes and hospitalization for cardiac failure. All major
events were obtained by direct contact with the patient or their
relatives.
2.4. Statistical analysis
Continuous variables are expressed as mean  standard devia-
tion. A 2-tailed Student’s t test was used to test differences among
continuous variables. Differences between categorical variables were
analyzed with a chi-square test or Fisher’s exact test. A p value of
<0.05 was considered signiﬁcant. All data were processed using the
Statistical Package for Social Sciences, version 15 (SPSS Inc., Chicago,
Illinois).
3. Results
Population baseline characteristics are summarized in Table 1
and main angiographic data are presented in Table 2. Procedural
characteristics are shown in Table 3. The total procedural success
rate was 100%. Immediate procedural success rate after ‘‘mini-
crush’’ stent technique alone was 85%. In 12% of cases, an
additional in-stent stent was implanted in the side branch using a T
and Protrusion technique (TAP) with repeat SFKB due to a non-
acceptable angiographic result on the side branch after the ﬁrst
SFKB. As well in 3 cases (3%) with non-satisfactory angiographic
result after mini-crush technique and SFKB, an additional in-stent
simultaneous kissing stenting was performed using two DES
simultaneously deployed at 20 atm. All the side branches and 98%
of main vessels received a DES. Two patients had implantation of a
bare metal stent in the main vessel due to a large diameter (4 and
4.5 mm, respectively). The mean maximal pressure of stent
deployment in the main vessel was 20  1 atm, ranging fromressure stent deployment on angiographic and long-term clinical
rush stent technique: A single center experience, Indian Heart J.
Table 3
Procedural characteristics (n = 113).
Sheath size 6 Fr/7 Fr/8 Fr (%) 48/49/3
Dual access (%) 5.3
Radial access (%) 50.44
Femoral access (%) 54.86
BMS stents SB (%) 0
DES stents SB (%) 100
BMS stents MV (%) 1.76
DES stents MV (%) 98.23
Max pressure inﬂation MV (atm) 20  1.4
Max pressure inﬂation SB (atm) 20  1.46
HP SFKB (%) 92.03
Max pressure MV SFKB (atm) 18.63  3.55
Max pressure SB SFKB (atm) 17.08  3.36
T and protrusion (%) 12.38
Simultaneous kissing stent (%) 2.65
Failing re-wire (%) 0
Slow ﬂow SB during crush (%) 2.65
BMS, bar metal stent; DES, drug eluting stent; SB, side branch;
MV, main vessel; SFKB, simultaneous ﬁnal kissing balloon; HP,
high pressure.
Table 4
Main events in angiographical and clinical follow up.
Angiographic FU (%) 83
Restenosis at 6 month FU (%) 13
Restenosis SB (%) 11
Restenosis MV (%) 2
Thrombosis (%) 1.8
Death all cause (%) 3.6
Death CV (%) 3.6
Death non-CV (%) 0
MI Q wave (%) 1.8
TLR (%) 8
TVR (%) 11
FU, follow up; SB, side branch; MV, main vessel; CV,
cardiovascular; TLR, target lesion revascularization; TVR, target
vessel revascularization.
Table 2
Angiographic characteristics of bifurcations lesions (n = 113).
Medina (1, 1, 1) (%) 100
Localization of BLs
Left main (%) 2.65
Left anterior descending artery (%) 62.83
Circumﬂex artery (%) 26.54
Right coronary artery (%) 6.19
Main vessel size (mm) 3.01  0.39
Distal vessel size (mm) 2.37  0.17
Main vessel lesion length (mm) 23.90  6.34
Side branch lesion length (mm) 16.96  5.89
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25 atm. A SFKB was used in 92% of cases with non-compliant balloon
inﬂation mean pressure of 19  3 atm (range 16–30 atm) in the MV
and 17  3 atm in the SB (range 16–25 atm). In 9 cases, the operator
did not perform any SFKB because of an optimized angiographic
result. There was no failure to re-cross the crush stent with a guide
wire. In one case, a speciﬁc guide-wire with higher stiffness (Miracle
3, Asahi Intecc, Osaka, Japan) was used to re-cross the stents struts.
We documented 3 cases of transient slow ﬂow after crushing the SB
stent that disappeared immediately after nitroglycerin intracoronary
injection. No case of vessel rupture and major dissections was noted.
No acute or subacute stent thrombosis occurred in the 30 days.
3.1. Angiographic follow-up
Angiographic follow-up was obtained in 94 patients (83%).
Global angiographic restenosis at 6 months occurred in 15 patients
(13%) including restenosis at the SB in 13 patients (11%) and
restenosis at the main vessel in 2 cases (2%). One case of probable
SB stent thrombosis was found at control angiogram. Restenosis
occurred in 2 of the 16 cases (12.5%) in which in-stent stents had
been implanted using either a TAP technique or a simultaneous
kissing stenting. Dyslipidemia, diabetes, smoking, hypertension,
male gender, stent deployment pressure, stent length, generation
of stent and BL location were not signiﬁcantly predictive factors of
restenosis. Global restenosis was higher in ﬁrst generation DES
than in second generation DES (20% vs 13%) but the difference did
not achieve statistical signiﬁcance (p = 0.3). All non-occlusive
restenoses were focal.
3.2. Clinical follow-up
Clinical follow-up was completed for all patients with a median
of 37  18 months. During the whole follow-up, TVR and TLR werePlease cite this article in press as: Gerbay A, et al. Impact of very high p
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(2016), http://dx.doi.org/10.1016/j.ihj.2016.05.013performed in 13 patients (11%) and 9 patients (8%), respectively. TVR
or TLR were clinically ischemia driven in only 4 patients whereas in
7 patients, repeat revascularization was performed based on the
ﬁndings at 6 months control angiogram in asymptomatic patients.
Seven of the 15 patients with restenosis underwent repeat PCI with
in-stent stenting using new DES and the remaining 8 restenotic
patients were treated medically without PCI as they were asymp-
tomatic with an intermediate stenosis (50–70% diameter stenosis) on
the SB. Four patients died during the follow-up. Among these
4 deceased patients, one patient presented a very late stent
thrombosis. This patient suffered a very late probable stent
thrombosis 5 years after stent implantation but this patient was
only under oral anticoagulation treatment for atrial ﬁbrillation
without any antiplatelet therapy. The three other patients died from
ischemic stroke (Table 4).
4. Discussion
To our knowledge, the present study is the ﬁrst one to report a
large series of true coronary bifurcation lesions treated by PCI
using a mini-crush stent technique with DES deployment at very
high inﬂation pressure (20 atm). The main ﬁndings of our study
are: (1) the absence of acute or subacute stent thrombosis, (2) an
extremely low rate of late stent thrombosis (0.9%), (3) a low
angiographic restenosis rate, (4) a low cumulative MACE rate in the
follow-up and a very low rate of clinically ischemia driven repeat
revascularization (4%) at a 3 years follow-up.
The rationale for using very high-pressure stent deployment is
to maximize stent expansion and to avoid malapposition of the
stent struts to the vessel wall14 that is recognized to be a major
mechanism for stent thrombosis.15,16 Conversely, experimental
animal studies17–19 have suggested that high-pressure implanta-
tion could increase the major adverse cardiac events. There is,
however, very few published clinical data regarding the impact of
stent deployment inﬂation pressure level on angiographic and
clinical outcomes. In a non-randomized study, Uretsky et al.11
found that very high inﬂation pressure had similar acute and short-
term results when compared with less aggressive inﬂation
pressure strategy but very high inﬂation pressure was associated
with a poorer long-term outcome including both higher rates of
MACE and TLR. By contrast, in a randomized trial, Dirschinger
et al.12 found no signiﬁcant difference between low- and high-
pressure dilatation during stent placement on early and late
angiographic and clinical outcome. However, in both these latter
studies,11,12 only bare metal stents were used and no details were
available regarding the subgroup of bifurcation lesions. The
concept of high inﬂation pressure to optimize stent apposition
may actually be more clinically relevant in true bifurcation lesions
treated by DES using a 2-stent technique rather than in simple
lesions receiving bare metal stents or in bifurcations treated by
one-DES technique. In particular, intravascular ultrasound studiesressure stent deployment on angiographic and long-term clinical
rush stent technique: A single center experience, Indian Heart J.
Table 5
Overview of previous studies with crush technique stenting in BL with angiographic follow up.
Study author Year Patients with angio F-U (%) Pressure kissing balloon (atm) Pressure stent deployment (atm) Restenosis (%)
MV/SB
Thrombosis (%) Center
Tanabe et al. 2004 68 – – 23 6.5 Mono
Hoye et al. 2006 77 – – 25 5.6 Multi
Galassi et al. 2007 93 – – 12/2 2.2 Mono
Erglis et al. 2009 88 – – 12 1.4 Multi
Galassi et al. 2009 82 – – 12/9 2 Mono
Chen et al. 2011 92 – – 5/4 2.7 Multi
Cheema et al. 2013 87 – – 28 2 Mono
Kervinen et al. 2013 –
Ge et al. 2005 80 – 15.3 12/22 4.5 Mono
Ge et al. 2006 79 – 15.2 16/19 3.3 Mono
Chen et al. 2008 83 16.5 20 3.2 Mono
Yang et al. 2009 83.9 8.6 14.7 2/13 2 Mono
Colombo et al. 2009 86 – 14.3 5/13 1.7 Multi
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techniques,20 a frequently used 2-stent approach, to improve
angiographic and clinical outcomes. However, no clinical data exist
regarding the impact of DES deployment at very high inﬂation
pressure in crushing techniques. Several studies on BL treated by
crushing techniques with routine angiographic follow-up have
been previously published6,8–10,21–30 but only a few studies8,10,28–
30 have provided details on stent deployment pressures (Table 5).
In these 5 latter previously reported studies,8,10,28–30 maximal
pressures used for stent deployment were lower than in our study
(15 vs 20 atm). The ﬁnal kissing balloon mean inﬂation pressure
was also high in our study since it was 19 atm for the MV and
17 atm for the SB. Comparison with other studies regarding the
impact of inﬂation pressure level during ﬁnal kissing balloon in
bifurcation lesions treated by 2-stent technique remains difﬁcult
since details on inﬂation pressure are usually not provided in
previously published studies.6,8–10,21–30 Final kissing balloon in
crushing techniques has been shown to correlate with more
favorable long-term outcomes.25 We believe that ﬁnal kissing
balloon at high-pressure in 2-stent technique following initial
SDHP may also improve stents apposition and therefore contribute
to reduce acute and sub-acute occlusion rates as well as to achieve
better angiographic and clinical long-term outcomes.
Indeed, in our study we did not observe any case of acute or sub-
acute stent thrombosis (0%) and only one patient (0.9%) presented
a late stent thrombosis. One additional case of probable very late
stent thrombosis occurred at 5 years and the total rate of stent
thrombosis over a mean follow-up of 3 years was therefore only
1.8%. These numbers appear to be quite low when compared with
other previously published studies on crushing techniques8,10,28–30
in which stent deployment inﬂation pressures were lower since, in
these latter studies, the mean rate of stent thrombosis was 2.3%
(1.7–3.2%) over relatively short follow-up ranging from 8 to
12 months. Our results appear to be even more encouraging
considering the fact that all our patients (100%) had Medina type
[1, 1, 1] bifurcation that is expected to be the most unfavorable
lesion in term of restenosis rate.
By contrast with ﬁndings of Uretsky et al.,11 we did not ﬁnd that
patients treated with aggressive SDHP strategy were associated
with increased long-term MACE. In a series of 136 patients
undergoing PCI with bare metal stents, Uretsky et al.11 found at a
405 days follow-up that very high inﬂation pressures were
associated with more frequent pattern of diffuse restenosis and
higher rates of TLR than lower inﬂation pressures (71% vs 16% and
27% vs 8%, respectively). Our own data are in disagreement with
those of Uretsky et al.11 since despite a longer follow-up (mean of
1110 days), the total TLR rate was only 6% in our study including
only a 4% of clinically ischemia driven TLR with no case of diffuse
restenosis. The differences between our study and that of UretskyPlease cite this article in press as: Gerbay A, et al. Impact of very high p
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(2016), http://dx.doi.org/10.1016/j.ihj.2016.05.013et al.11 may be largely explained by the current use of DES in our
work. When compared with bare metal stents, DES might require
higher inﬂation pressures to ensure optimized stent apposition
and to improve both angiographic and clinical outcomes.
The cumulative MACE rate in our study was only 14% during a
37 months follow-up whereas it was 23% (range 16–27%) at shorter
follow-up periods of 8–12 months in the other previously
published studies on crush techniques with DES deployment
lower inﬂation pressures.8,10,28–30
It has been suggested that a double kissing balloon might avoid
slow ﬂow in the SB during crushing and might facilitate recrossing
of the MV stent struts into the SB with the guidewire and the
balloon.28 In our work, we had only three transient slow-ﬂow in
the SB during crushing and we did not have any failure of
recrossing the MV stent struts into the SB with the guidewire
followed by the balloon. The use of high inﬂation pressures may
probably facilitate the maneuvers of recrossing the stent struts by
the guidewire and the balloon to achieve a ﬁnal kissing balloon.
4.1. Study limitation
The main limitation of our study is the absence of a control
group of patients with lower stent deployment inﬂation pressures.
Despite the good results of our study when compared with those of
studies previously published by others, a randomized trial
comparing very high with lower inﬂation pressures is necessary
to deﬁnitely conﬁrm our ﬁndings. This is a single center
experience. The advantage is the consistent technology and the
disadvantage the limited generalization of the data.
5. Conclusion
Our data suggest that very high inﬂation pressures during drug
eluting stent placement in true bifurcation lesions treated by a
mini-crush technique show feasibility with promising results that
need to be veriﬁed in larger, preferably randomized trials.
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